Literature DB >> 19963435

Early diagnosis of dengue in travelers: comparison of a novel real-time RT-PCR, NS1 antigen detection and serology.

Eili Huhtamo1, Essi Hasu, Nathalie Y Uzcátegui, Elina Erra, Simo Nikkari, Anu Kantele, Olli Vapalahti, Heli Piiparinen.   

Abstract

BACKGROUND: The increased traveling to dengue endemic regions and the numerous epidemics have led to a rise in imported dengue. The laboratory diagnosis of acute dengue requires several types of tests and often paired samples are needed for obtaining reliable results. Although several diagnostic methods are available, proper comparative data on their performance are lacking.
OBJECTIVES: To compare the performance of novel methods including a novel pan-DENV real-time RT-PCR and a commercially available NS1 capture-EIA in regard to IgM detection for optimizing the early diagnosis of DENV in travelers. STUDY
DESIGN: A panel of 99 selected early phase serum samples of dengue patients was studied by real-time RT-PCR, NS1 antigen ELISA, IgM-EIA, IgG-IFA and cell culture virus isolation.
RESULTS: The novel real-time RT-PCR was shown specific and sensitive for detection of DENV-1-4 RNA and suitable for diagnostic use. The diagnostic rate using combination of RNA and IgM detection was 99% and using NS1 and IgM detection 95.9%. The results of RNA and NS1 antigen detection disagreed in 15.5% of samples that had only RNA or NS1 antigen detected.
CONCLUSIONS: The diagnostic rates of early samples are higher when either RNA or NS1 antigen detection is combined with IgM detection. Besides the differences in the RNA and NS1 detection assays, the observed discrepancy of results could suggest individual variation or differences in timing of these markers in patient serum. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19963435     DOI: 10.1016/j.jcv.2009.11.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  35 in total

1.  Antibody-based assay discriminates Zika virus infection from other flaviviruses.

Authors:  Angel Balmaseda; Karin Stettler; Raquel Medialdea-Carrera; Damaris Collado; Xia Jin; José Victor Zambrana; Stefano Jaconi; Elisabetta Cameroni; Saira Saborio; Francesca Rovida; Elena Percivalle; Samreen Ijaz; Steve Dicks; Ines Ushiro-Lumb; Luisa Barzon; Patricia Siqueira; David W G Brown; Fausto Baldanti; Richard Tedder; Maria Zambon; A M Bispo de Filippis; Eva Harris; Davide Corti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

2.  First case of Zika virus infection in a returning Canadian traveler.

Authors:  Kevin Fonseca; Bonnie Meatherall; Danielle Zarra; Michael Drebot; Judy MacDonald; Kanti Pabbaraju; Sallene Wong; Patricia Webster; Robbin Lindsay; Raymond Tellier
Journal:  Am J Trop Med Hyg       Date:  2014-10-06       Impact factor: 2.345

3.  Zika and chikungunya virus infections in hematopoietic stem cell transplant recipients and oncohematological patients.

Authors:  Clarisse Martins Machado; Bárbara Brito de Souza Pereira; Alvina Clara Felix; Maria Carolina Oliveira; Luiz Guilherme Darrigo; Mair Pedro de Souza; Eduardo José de Alencar Paton; Fabia Neves; Vergilio Rensi Colturato; Belinda Pinto Simoes
Journal:  Blood Adv       Date:  2017-04-10

4.  Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers.

Authors:  Willem G van Panhuis; Robert V Gibbons; Timothy P Endy; Alan L Rothman; Anon Srikiatkhachorn; Ananda Nisalak; Donald S Burke; Derek A T Cummings
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

5.  Viral metagenomics in blood donations with post-donation illness reports from Brazil.

Authors:  Rafael Dos Santos Bezerra; Leonardo Scalon de Oliveira; Edson L Moretto; Eugênia M Amorim Ubiali; Roberta Maraninchi Silveira; Wilson A da Silva; Dimas Tadeu Covas; Simone Kashima; Svetoslav N Slavov
Journal:  Blood Transfus       Date:  2020-07-22       Impact factor: 3.443

6.  Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore.

Authors:  Yee Sin Leo; Anneliese Wilder-Smith; Sophia Archuleta; Lynette P Shek; Chia-Yin Chong; Hoe Nam Leong; Chian Yong Low; May-Lin Helen Oh; Alain Bouckenooghe; T Anh Wartel; Denis Crevat
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

7.  Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection.

Authors:  Lyda Osorio; Meleny Ramirez; Anilza Bonelo; Luis A Villar; Beatriz Parra
Journal:  Virol J       Date:  2010-12-06       Impact factor: 4.099

8.  Dengue: a new challenge for neurology.

Authors:  Marzia Puccioni-Sohler; Marco Orsini; Cristiane N Soares
Journal:  Neurol Int       Date:  2012-11-13

9.  Dengue in travelers: kinetics of viremia and NS1 antigenemia and their associations with clinical parameters.

Authors:  Elina O Erra; Essi M Korhonen; Liina Voutilainen; Eili Huhtamo; Olli Vapalahti; Anu Kantele
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

10.  Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus.

Authors:  Gilberto A Santiago; Edgardo Vergne; Yashira Quiles; Joan Cosme; Jesus Vazquez; Juan F Medina; Freddy Medina; Candimar Colón; Harold Margolis; Jorge L Muñoz-Jordán
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.